Researchers Oregon center of stem cells in Oregon Health and Science University (OHSU) and the Center for medical consultations on the digestive OHSU gave new hope to patients with pancreatic cancer. Scientists have developed new reagents (or antibodies) that can detect cancer cells, reports Science Daily.

New antibodies react to a small number of normal cells of the pancreas, in particular those that are involved in moving proteins from the gland, and much more - to cancerous tissue cells. In addition, the data also reveal reagents gastrointestinal cancer tumors. According to Brett Sheppard, one of the researchers, in the next phase of scientists hold high-screening tests of these antibodies to determine their full potential in the diagnosis of deadly diseases.

As reported by Compulenta, to date only 15% of cases properly cancer in early stages. Unfortunately, the signs and symptoms of the disease usually appear only in the late stages of cancer development, when the surgery - the best and only way to treat pancreatic cancer - is no longer possible.

Head of research Philip Streeter confident that the new antibodies to develop methods of identifying the disease in early stages and create new ways to treat it, and early detection of disease, in turn, help to save a large number of lives.